Kallikrein 15 (KLK15) Human shRNA Plasmid Kit (Locus ID 55554)

Specifications

Product Data
Product Name	Kallikrein 15 (KLK15) Human shRNA Plasmid Kit (Locus ID 55554)
Locus ID	55554
UniProt ID	Q9H2R5
Synonyms	ACO; HSRNASPH
Vector	pGFP-C-shLenti
Format	Lentiviral plasmids
Kit Components	KLK15 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 55554). 5µg purified plasmid DNA per construct 29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free.
RefSeq	NM_001277081, NM_001277082, NM_017509, NM_023006, NM_138563, NM_138564, NR_102274, NM_017509.1, NM_017509.2, NM_017509.3, NM_138564.1, NM_138563.1, NM_001277082.1, NM_001277081.1, NM_023006.1, BC069507, BC069507.1, BC069480, BC069518, BC126137, BC144045, BC144046, BC144047
Summary	Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. In prostate cancer, this gene has increased expression, which indicates its possible use as a diagnostic or prognostic marker for prostate cancer. The gene contains multiple polyadenylation sites and alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
shRNA Design	These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed	OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.